Ying Wang, L. S. (2018). Adȷuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice [Immunology and Inflammation]. National Academy of Sciences.
Chicago Style (17th ed.) CitationYing Wang, Lijing Su. Adȷuvant Effect of the Novel TLR1/TLR2 Agonist Diprovocim Synergizes with Anti-PD-L1 to Eliminate Melanoma in Mice [Immunology and Inflammation]. National Academy of Sciences, 2018.
MLA (9th ed.) CitationYing Wang, Lijing Su. Adȷuvant Effect of the Novel TLR1/TLR2 Agonist Diprovocim Synergizes with Anti-PD-L1 to Eliminate Melanoma in Mice [Immunology and Inflammation]. National Academy of Sciences, 2018.
Warning: These citations may not always be 100% accurate.